COVID-19 Vaccine Response in People With Multiple Sclerosis Treated With Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy

61 views
May 8, 2024
Comments 0
Login to view comments. Click here to Login